---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------
---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
 |
 |
 Pharmacist e-Link CE Spotlight |
 |
 |
The Safety of COX-2 Pharmacotherapy for Patients in Pain
There are anecdotal reports about the COX-2 inhibitors of improved efficacy over the traditional NSAIDs. This program will help the practitioner identify those patients with specific risk factors, in whom the risks would outweigh potential benefits, and properly educate those for whom COX-2 use is still an option.
This program is supported by an educational grant from Pfizer Inc. |
|
 |
Quality Improvement Opportunities in Managing Depression—
Measuring Performance Through Benchmarking
This activity will discuss the effect of depression on both patients and employers, and review the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) diagnostic criteria and American Psychiatric Association Practice Guidelines. Also, the 2006 HEDIS® (Health Plan Employer Data and Information Set) antidepressant medication management measures will be discussed, with a focus on strategies for optimizing the management of patients with depression.
This activity is supported by an educational grant from Wyeth Pharmaceuticals. |
 |
Insulin Delivery Systems and Their Role in the Treatment of Diabetes
The goal of this activity is to provide healthcare professionals with information on current and investigational methods of insulin delivery to help them guide patients in selecting the most suitable method of insulin delivery.
This program is supported by an educational grant from Novo Nordisk Inc. |
 |
Novel Therapies to Reduce Cardiometabolic Risk Factors
New and novel therapies are emerging that affect the endocannabinoid system (ECS). These therapies impact on the regulation of food intake and fat accumulation, as well as lipid and glucose metabolism.
This activity has been developed and provided by The GMR Group-Health Insights and is supported by an educational grant from Sanofi-Aventis. |
 |
New Approaches and Patient Counseling in the Treatment of Osteoporosis
Osteoporosis will create a significant problem with severe lifestyle impact to one in two women and one in four men over 50 years of age – many of your pharmacy patients. This program brings you insight to treatment of this patient population.
Commercial Support Provided by Roche Laboratories Inc. and GlaxoSmithKline. |
 |
Medication Errors and the Medication Use System:
How Do We Improve?
Health care professionals have been trained to "first do no harm" when taking care of patients. The primary components to be discussed include the terminology when identifying events, reporting mechanisms and their effectiveness, the use of data that are reported, and some best practices that all organizations should be addressing.
This program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. |
|
|
